285 related articles for article (PubMed ID: 24998547)
1. Lack of association between the matrix metalloproteinase-2 -1306C>T polymorphism and breast cancer susceptibility: a meta-analysis.
Yang L; Li N; Wang S; Kong Y; Tang H; Xie X; Xie X
Asian Pac J Cancer Prev; 2014; 15(12):4823-7. PubMed ID: 24998547
[TBL] [Abstract][Full Text] [Related]
2. Association between MMP2-1306 C/T polymorphism and prostate cancer susceptibility: a meta-analysis based on 3906 subjects.
Zhang K; Chen X; Zhou J; Yang C; Zhang M; Chao M; Zhang L; Liang C
Oncotarget; 2017 Jul; 8(27):45020-45029. PubMed ID: 28445160
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects.
McColgan P; Sharma P
Int J Cancer; 2009 Sep; 125(6):1473-8. PubMed ID: 19507256
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-2 -1306 C>T gene polymorphism is associated with reduced risk of cancer: a meta-analysis.
Haque S; Akhter N; Lohani M; Ali A; Mandal RK
Asian Pac J Cancer Prev; 2015; 16(3):889-96. PubMed ID: 25735378
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of MMP2 -1306T allele as a protective factor in digestive cancer.
Zhang LY; Ren KW
Arch Med Res; 2011 Apr; 42(3):239-43. PubMed ID: 21722821
[TBL] [Abstract][Full Text] [Related]
7. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
8. MMP-2 -1306C>T polymorphism in breast cancer: a case-control study in a South European population.
Zagouri F; Sergentanis TN; Gazouli M; Dimitrakakis C; Tsigginou A; Papaspyrou I; Chrysikos D; Lymperi M; Zografos GC; Antsaklis A; Dimopoulos MA; Papadimitriou CA
Mol Biol Rep; 2013 Aug; 40(8):5035-40. PubMed ID: 23661021
[TBL] [Abstract][Full Text] [Related]
9. No association of the TGF-β1 29T/C polymorphism with breast cancer risk in Caucasian and Asian populations: evidence from a meta-analysis involving 55,841 subjects.
Alqumber MA; Dar SA; Haque S; Wahid M; Singh R; Akhter N
Asian Pac J Cancer Prev; 2014; 15(20):8725-34. PubMed ID: 25374198
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-2 promoter polymorphism is associated with breast cancer in a Mexican population.
Delgado-Enciso I; Cepeda-Lopez FR; Monrroy-Guizar EA; Bautista-Lam JR; Andrade-Soto M; Jonguitud-Olguin G; Rodriguez-Hernandez A; Anaya-Ventura A; Baltazar-Rodriguez LM; Orozco-Ruiz M; Soriano-Hernandez AD; Rodriguez-Sanchez IP; Lugo-Trampe A; Espinoza-Gomez F; Michel-Peregrina ML
Gynecol Obstet Invest; 2008; 65(1):68-72. PubMed ID: 17851253
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis on the relationship between the SNP of MMP-2-1306 C>T and susceptibility to breast cancer.
Ou YX; Bi R
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1264-1270. PubMed ID: 32096157
[TBL] [Abstract][Full Text] [Related]
12. Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.
Chen MB; Li C; Shen WX; Guo YJ; Shen W; Lu PH
Mol Biol Rep; 2011 Oct; 38(7):4687-95. PubMed ID: 21127985
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
14. The MMP-2 -735 C allele is a risk factor for susceptibility to breast cancer.
Yari K; Rahimi Z; Moradi MT; Rahimi Z
Asian Pac J Cancer Prev; 2014; 15(15):6199-203. PubMed ID: 25124598
[TBL] [Abstract][Full Text] [Related]
15. The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis.
Yan Y; Liang H; Li T; Li M; Li R; Qin X; Li S
Tumour Biol; 2014 Apr; 35(4):3047-52. PubMed ID: 24390660
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 -1562T allele and its combination with MMP-2 -735 C allele are risk factors for breast cancer.
Rahimi Z; Yari K; Rahimi Z
Asian Pac J Cancer Prev; 2015; 16(3):1175-9. PubMed ID: 25735351
[TBL] [Abstract][Full Text] [Related]
17. Association between ERα gene Pvu II polymorphism and breast cancer susceptibility: A meta-analysis.
Zhang ZL; Zhang CZ; Li Y; Zhao ZH; Yang SE
Medicine (Baltimore); 2018 Apr; 97(17):e0317. PubMed ID: 29702977
[TBL] [Abstract][Full Text] [Related]
18. Association between BRCA1 rs799917 polymorphism and breast cancer risk: A meta-analysis of 19,878 subjects.
Qin TT; Chen T; Zhang Q; Du HN; Shu YQ; Luo K; Zhu LJ
Biomed Pharmacother; 2014 Sep; 68(7):905-10. PubMed ID: 25194442
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
[TBL] [Abstract][Full Text] [Related]
20. The protective role of the -1306C>T functional polymorphism in matrix metalloproteinase-2 gene is associated with cervical cancer: implication of human papillomavirus infection.
Singh N; Hussain S; Sharma U; Suri V; Nijhawan R; Bharadwaj M; Sobti RC
Tumour Biol; 2016 Apr; 37(4):5295-303. PubMed ID: 26561467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
